We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    hepatocellular carcinoma sorafenib mFOLFOX
Previous Study | Return to List | Next Study

Sorafenib + mFOLFOX for Hepatocellular Carcinoma

This study is currently recruiting participants.
Verified January 2017 by Andrew X. Zhu, MD, Massachusetts General Hospital
Sponsor:
ClinicalTrials.gov Identifier:
NCT01775501
First Posted: January 25, 2013
Last Update Posted: February 2, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Andrew X. Zhu, MD, Massachusetts General Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2017
  Estimated Primary Completion Date: May 2017 (Final data collection date for primary outcome measure)